Epidemiological and clinical aspects of methicillin resistance and enterotoxin production in Staphylococcus aureus.
D001434:Bacteriophage Typing; D003030:Coagulase / Q000378:metabolism; D003428:Cross Infection / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology* / Q000401:mortality; D004196:Disease Outbreaks; D004761:Enterocolitis, Pseudomembranous / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology* / Q000401:mortality; D004768:Enterotoxins / Q000096:biosynthesis*; D006460:Hemolysin Proteins / Q000096:biosynthesis; D006801:Humans; D008049:Lipase / Q000378:metabolism; D008712:Methicillin / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D010403:Penicillin Resistance; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology* / Q000401:mortality; D013210:Staphylococcus / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism*; D013548:Sweden
D003030:Coagulase; D004768:Enterotoxins; D006460:Hemolysin Proteins; D008049:Lipase; D008712:Methicillin